Spain offers a comprehensive range of European Medicines Agency (EMA) approved anti-seizure medications, including Levetiracetam, Lamotrigine, and Valproic acid. Recent approvals like Cenobamate and Brivaracetam ensure access to modern therapies. Treatment focuses on personalized selection based on video-EEG monitoring at Joint Commission International-accredited centers in Barcelona and Madrid.
- Common medications: Options include Lamotrigine (Lamictal), Levetiracetam (Keppra), and Lacosamide (Vimpat) for various seizure types.
- Modern approvals: Newer drugs like Cenobamate (Ontozry) and Eslicarbazepine (Zebinix) are actively funded and available.
- Clinical success: Specialized neurologists achieve 70% seizure freedom rates through precise, non-surgical drug therapy adjustments.
- Expert centers: Facilities like Centro Médico Teknon utilize advanced EEG to refine individual medication plans.
Bookimed Expert Insight: While basic medications are widely available, the highest success rates in Spain come from specialized drug-resistant epilepsy units. Prof. Antonio Russi at Centro Médico Teknon, with 1,500+ procedures, often identifies incorrect prior diagnoses. This allows for specific medication switches that may not be standard in other countries.
Patient Consensus: Patients emphasize that Spanish neurologists must rewrite all foreign prescriptions to access local pharmacies. Many report that medications become virtually free once registered under the Spanish social security system.